J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
The Janssen Pharmaceutical, a Johnson & Johnson company, reported the U.S. Food and Drug Administration (FDA) granted its JNJ-6372 Breakthrough Therapy Designation. The drug...
Silverback Therapeutics Raises $78.5 Million to Advance Cancer Antibody Conjugates for Solid Tumors
Silverback Therapeutics, headquartered in Seattle, closed on an oversubscribed Series B financing round worth $78.5 million. It was led by U.S. Venture Partners with...
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
The new Agilent...
Recipharm supports FDA approval of Perrigos AB-rated generic product
Recipharm, a leading contract development and manufacturing organisation (CDMO), is pleased to note the FDA’s approval of Perrigo’s AB-rated generic of ProAir HFA (albuterol).
Bespak...
Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19
The epidemic of COVID-19 remains a prominent healthcare challenge, affecting more than 70 countries and regions over the world. This rapid widespread has made...
Generex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus Pandemic
Generex Biotechnology Corporation is pleased to announce that the company has signed a contract with EpiVax to use their computational tools to predict epitopes...
Regeneron to develop antibodies for novel coronavirus with HHS support
Regeneron Pharmaceuticals has expanded its collaboration with the US Department of Health and Human Services (HHS) to develop antibody treatments for novel coronavirus (2019-nCoV).
Recently...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...